Dermal Fillers Market To Expand Substantially Between 2020 And 2028 As Demand For Aesthetic Medical Treatments Rises
Research Nester released a report titled “Dermal Fillers Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global dermal fillers market in terms of market segmentation by ingredient, by product, by application and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
The market for dermal fillers is projected to grow at a CAGR of around 8% during the forecast period, i.e., 2020-2028. Dermal fillers are materials injected into the skin in order to restore and enhance the facial structure. A number of dermal fillers have been approved by the U.S. FDA and are being used by cosmetic surgeons all across the world.
Dermal fillers market is segmented by ingredient, by product, by application and by region, out of which, the market is further segmented on the basis of ingredients into hyaluronic acid, calcium hydroxylapatite, collagen, poly-L lactic acid, PMMA [poly methyl methacrylate] and others. The hyaluronic acid segment is anticipated to hold the largest share in the market as a result of its highly desirable properties, including high water retention, increased safety, improved efficacy and anti-ageing.
The market is segmented on the basis of region into five major regions, consisting of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Dermal fillers is anticipated to observe a high market growth in North America and hold the largest share in the region. This can be attributed to the rising demand for highly effective and advanced dermal fillers for aesthetic medical treatments. Apart from this, the market for dermal fillers in Asia Pacific is estimated to grow at a significantly high rate on the back of growing demand for the product for scar removal and other medical treatments.
Utility of Dermal Fillers among Elderly Population to Increase in Coming Years
As per the American Society of Plastic Surgeons, the number of minimally-invasive cosmetic procedures involving soft tissue fillers among people between the ages 40 and 54 was found to be 49% of total procedures in the United States. Similarly, 37% of all procedures involved soft tissue fillers in 2018.
This data suggests that people above the age of 40 are highly likely to undergo procedures that use soft tissue fillers and are minimally invasive in order to look younger and enhance the facial figure. This is predicted to be a major factor responsible for the market growth in the upcoming years. However, the high costs associated with such treatments restricts a large section of the population from spending on them, which is estimated to restrain the market growth.
This report also provides the existing competitive scenario of some of the key players of the global dermal fillers market which includes company profiling of Allergan (NYSE: AGN), Merz Pharma, Sinclair Pharma, Galderma Laboratories, BioPlus Co., Ltd., Candela Corporation, BIOXIS pharmaceuticals, Suneva Medical, SCULPT Luxury Dermal Fillers Ltd and Dr. Korman Laboratories Ltd. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global dermal fillers market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.